| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 10 | |
| #2 | Canada | 4 | |
| #3 | WIPO (World Intellectual Property Organization) | 4 | |
| #4 | United States | 3 | |
| #5 | Brazil | 2 | |
| #6 | China | 2 | |
| #7 | Republic of Korea | 2 | |
| #8 | Australia | 1 | |
| #9 | Hong Kong | 1 | |
| #10 | Mexico | 1 | |
| #11 | Russian Federation | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Ammer Richard | 27 |
| #2 | Baumstuemmler Bernd | 11 |
| #3 | Tuereli Akif Emre | 11 |
| #4 | Richard Ammer | 3 |
| #5 | Ballmann Christina | 1 |
| #6 | Poestges Reiner | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP3398601A1 | Nicotinamide for treating dyslipidemia | |
| EP3398600A1 | Modified release nicotinamide | |
| EP3069715A1 | Immediate release dosage forms of Atomoxetine | |
| EP2796133A1 | Sustained release guanfacine HCl formulation | |
| EP2641592A1 | Pharmaceutical formulation comprising bendamustine | |
| EP2465496A1 | Anti-acidosis pharmaceutical composition |